MGCD exhibited greater efficacy in male mice compared to female mice, suggesting that decreased NPRA/cGMP signaling is associated with sex‐dependent renal dysfunction, histomorphological damage, and hypertension to a greater extent in males than females at molecular level. The gene discussed is NPR1; the disease is Hypertension.